TING 2% Miconazole Nitrate Spray Recalled for Benzene Contamination
Insight Pharmaceuticals recalls TING 2% Miconazole Nitrate Athlete's Foot Spray due to benzene contamination. The recall affects 117,336 cans distributed nationwide and in Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I drug recall, which requires a minimum severity score of Severe (4) per the rubric. The presence of benzene, a known chemical contaminant, in a topical drug product poses a significant health risk, though no reported illnesses are documented in the source material.
Plain-English summary
Insight Pharmaceuticals Corporation is recalling TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder in 4.5 oz (128 g) cans due to contamination with benzene. The FDA classified this as a Class I recall.
The recall affects 117,336 cans distributed nationwide and in Puerto Rico. Affected lot numbers are 0H88645 (Expiration 07/31/2024) and 0B88345 (Expiration 02/29/2024), with product UPC 363736532611.
Benzene is a known chemical hazard. Consumers should refer to the FDA recall notice for specific instructions on what to do with affected product. For more information, consumers can contact Insight Pharmaceuticals LLC or visit the FDA website.
The recalled product
- Product
- TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder, NET WT 4.5 oz (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591, UPC 363736532611.
- Manufacturer
- Insight Pharmaceuticals Corporation
- Category
- Drug — Topical Antifungal
- Hazard
- benzene-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #s: 0H88645
- Exp 07/31/2024
- 0B88345
- Exp 02/29/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27